Here, we present a protocol that describes in detail both the computational and benchtop implementation of an arrayed and/or pooled crIspr genome-editing experiment. this protocol provides instructions for sgrna design with crIspor (computational tool for the design, evaluation, and cloning of sgrna sequences), experimental implementation, and analysis of the resulting high-throughput sequencing data with crIspresso (computational tool for analysis of genome-editing outcomes from deep-sequencing data). this protocol allows for design and execution of arrayed and pooled crIspr experiments in 4-5 weeks by non-experts, as well as computational data analysis that can be performed in 1-2 d by both computational and noncomputational biologists alike using web-based and/or command-line versions.
IntroDuctIon
The CRISPR nuclease system is a facile and robust genomeediting system that was originally identified as the driver of prokaryotic adaptive immunity to allow for resistance to bacteriophages [1] [2] [3] . This system has been subsequently repurposed for eukaryotic genome editing by heterologous expression of the CRISPR components in eukaryotic cells. Site-specific cleavage by Cas9 requires an RNA molecule to guide nucleases to specific genomic loci to initiate double-strand breaks (DSBs) 1, 2, 4 . Site-specific cleavage requires Watson-Crick base pairing of the RNA molecule to a corresponding genomic sequence upstream of a protospacer-adjacent motif (PAM) 1, 2 . The required RNA molecule for genome-editing experiments consists of a synthetic fusion of the prokaryotic tracrRNA and CRISPR RNA (crRNA) to create a chimeric sgRNA 5 . In contrast to Cas9, the Cpf1 nuclease does not require a tracrRNA and engenders DSBs downstream of its PAM sequence. Cpf1 requires a crRNA to create DSBs, which results in 5′ overhangs 4 .
CRISPR mutagenesis relies on engagement of endogenous DNA repair pathways after nuclease-mediated DSB induction has occurred. The principal repair pathways include nonhomologous end joining (NHEJ) and homology-directed repair (HDR). NHEJ repair is an error-prone pathway, which results in a heterogeneous spectrum of insertions/deletions (indels) primarily in the range of experiments or multiple sgRNAs for pooled experiments. Arrayed experiments are useful when a target can be mutagenized by one sgRNA. Pooled screening allows for targeting of a handful of genes up to genome-scale gene targeting [14] [15] [16] [17] . It also allows for saturating mutagenesis (tiling of sgRNA) experiments to identify functional sequence within noncoding regions 11, 12, 18 . This protocol can be used to design and execute arrayed or pooled genome-editing experiments. Furthermore, it can also be used for the design, implementation, and analysis of pooled screens for gene targeting, saturating mutagenesis of noncoding elements, or any other targeting strategies 11, 12, 19, 20 . It is important to note that computational skills are required for the command-line and Docker versions of CRISPOR and CRISPResso in this protocol. Specifically, users are required to have a basic understanding of how to execute a command in a terminal and how to navigate a Unix-based file system. However, web-based versions are also available that do not require these skills.
CRISPOR: sgRNA and PCR primer design for arrayed and pooled screen experiments CRISPOR (http://crispor.org) is a computational sgRNA design tool that predicts off-target cleavage sites and offers a variety of on-target efficiency scoring systems to assist sgRNA selection for more than 120 genomes using many different CRISPR nucleases (Supplementary Table 1) 9 . CRISPOR offers a variety of on-and off-target prediction scores that can aid in optimal sgRNA selection (Box 1) 9 . Analysis of on-target sgRNA efficiency can be predicted based on available scores and/or investigated experimentally by analysis of editing frequency. In addition to the numerous sgRNA efficiency prediction scores, CRISPOR offers automated primer design to facilitate PCR amplification of regions for deep-sequencing analysis to quantitate editing frequency. This involves PCR amplification of sequences flanking the DSB site for a given sgRNA. Similarly, CRISPOR offers computational prediction of off-target sites as well as PCR primers for deep-sequencing analysis of potential mutagenesis at these predicted off-target sites.
CRISPOR can also be used for the design of gene-targeted pooled screens by including exonic regions for sgRNA design as well as saturating mutagenesis screens. Alternatively, a list of gene names can be input into CRISPOR ('CRISPOR Batch') to aid in the design of large scale gene-targeted libraries, which includes non-targeting controls. This analysis includes automated design of the required oligonucleotides for library cloning.
Saturating mutagenesis involves using all PAM-restricted sgRNAs within a given region(s) in a pooled screening format to identify functional sequences 11, 12, 18 . Saturating mutagenesis can be used to analyze coding and noncoding elements in the genome or a combination of the two. Screen resolution is a function of PAM frequency and can be enhanced by PAM choice and/or a combination of nucleases with unique PAM sequences 12 . CRISPOR can be used to design saturating mutagenesis libraries by simply selecting all sgRNAs within the inputted region(s). This analysis also includes automated design of the required oligonucleotides for library cloning. It is particularly important to consider off-target prediction scores offered by CRISPOR for saturating mutagenesis screens, as repetitive sequences can confound screen results 12 . sgRNAs with high probability of off-target mutagenesis can be excluded at the library design stage or can be appropriately handled at the analysis stage after the experiments have been performed (Box 1).
CRISPResso: analysis of deep sequencing from arrayed or pooled sgRNA experiments
CRISPResso is a computational pipeline that enables accurate quantification and visualization of CRISPR genome-editing outcomes, as well as comprehensive evaluation of effects on coding Pooled genome-editing experiments are performed by designing multiple sgRNA using CRISPOR. After designing the sgRNAs, they are batch-cloned into pLentiGuide-puro, lentivirus is produced, cells are transduced at low multiplicity, and successful transductants are selected (successful transduction is indicated by curved lines). Phenotypic selection is performed (e.g., FACS, drug/toxin resistance, drug/toxin sensitivity, cell lethality/gene essentiality, cellular fitness/proliferation). After conclusion of the experiment, cells are pelleted, and genomic DNA is extracted. PCR primers specific (primer sequence is underlined) to the pLentiGuide-Puro construct are used to amplify regions flanking the cloned sgRNA sequence. Deep sequencing of the amplicon generated by construct-specific PCR is subsequently performed. sgRNAs present within the sample are enumerated by CRISPRessoCount.
several unique advantages for designing sgRNAs for genomeediting experiments. First, CRISPOR integrates multiple published on-target sgRNA efficiency scores, including those from Fusi et al. 47 , Chari et al. 48 , Xu et al. 49 , Doench et al. 24, 50 , Wang et al. 51 , Moreno-Mateos et al. 52 , Housden et al. 53 , Prox. GC 54 , -GG 55 , and Out-of-Frame 56 . It also offers previously published off-target prediction (MIT specificity score) 8 . Second, CRISPOR has been optimized to facilitate experimental implementation by providing automated primer design for both on-target and off-target deep-sequencing analysis. The primers and output files are further designed to be compatible for subsequent analysis by CRISPResso after the experiments have been completed. CRISPOR also offers features to automate oligonucleotide design for cloning pooled sgRNA libraries targeting both genes and noncoding regions. Taken together, CRISPOR provides an sgRNA design platform to facilitate experimental execution and downstream data analysis. Alternative computational tools to CRISPResso exist to evaluate genome-editing outcomes from deep-sequencing data [57] [58] [59] [60] [61] ; however, these tools offer limited analysis functionality for pooled amplicon sequencing or WGS data as compared with the CRISPResso suite. CrispRVariants is another tool that offers functionality to analyze deep-sequencing data by quantifying mosaicism and allele-specific gene editing, as well as multisequence alignment views 60 . CRISPR genome-editing reagents have taken many forms, including DNA, RNA, protein, and various combinations of each 62, 63 . Delivery of these reagents has also been attempted using a variety of methods, including electroporation, lipid-based transfection, and viral-mediated delivery 62, 63 . For further discussion of delivery methods for genome-editing reagents, refer to Yin et al. 64 . Pooled screening relies on the ability to deliver individual reagents to individual cells in batches 65 . Electroporation and lipidbased transfection methods offer limited ability to control the number of reagents (i.e., sgRNAs) delivered per cell; however, lentiviral transduction at low transduction rates (~30-50%) results in single lentiviral integrants per cell in the majority of cases 65 . Furthermore, lentivirus offers stable integration of the CRISPR reagents into each cell's genome. These features of lentivirus allow for pooled CRISPR experiments. Therefore, this protocol describes the use of lentivirus for both arrayed and pooled CRISPR experiments (Boxes 3 and 4).
Limitations of on-target prediction, off-target prediction, and indel analysis As described above, there are many tools available for both ontarget sgRNA efficiency and off-target cleavage prediction. Progress has been made toward enhancing the predictive value of these scores; however, although these predictions are useful to focus sgRNA selection for experimental design, experimental validation provides the definitive analysis of on-target and offtarget mutagenesis. Alternatively, experimental approaches have also been developed for unbiased genome-wide detection of Box 1 | Selection of sgRNA based on on-target and off-target prediction scores CRISPOR provides two separate types of predictions: on-target and off-target scores. Off-target scores try to estimate the off-target cleavage potential, which depends on the sequence similarity between the on-target sequence and predicted off-target sequences. Predictions are first calculated on the level of individual putative off-target sites using the cutting frequency determination (CFD) offtarget score 24 . An off-target site with a high off-target score is more likely to be cleaved than one with a low score. The scores of all off-target sites of a guide are then summarized into the 'guide specificity score' . It ranges from 0 to 100; a guide with a high specificity score is expected to have fewer off-target sites and/or off-target sites with lower cleavage frequencies than one with a lower score. It was previously shown that guides with specificity scores > 50 never lead to more than around a dozen off-targets and none had a total off-target cleavage > 10% in whole-genome assays 9 . These guides are shown in green by CRISPOR.
On the level of the individual site, off-targets with a CFD score < 0.02 are very unlikely to be cleaved based on previous analysis that demonstrated only a few true off-target events with such a score (Haeussler et al. 9 ). For off-target sites that are cleaved, the CFD score is well-correlated with editing frequency, but predicted off-target sites are known to be primarily false positives. As such, for most guides, more than 95% of predicted off-target sites will not show any cleavage detectable with the sequencing depths in use at present. In addition, as summarized in Haeussler et al. 9 , a few guides with low specificity scores (in the range of 10-30) lead to fewer than three to five detected off-targets, so low specificity scores do not always translate to strong off-target effects.
The other type of prediction is on-target scoring, which tries to estimate on-target cleavage efficiency and depends only on the target sequence. CRISPOR offers eight algorithms in total, with two scores identified as most predictive when compared on independent data sets (refer to Haeussler et al. for further details) 9 . The algorithm by Doench et al. 24 (herein referred to as the 'Doench 2016 score') is optimal for cell-culture-based assays in which the guide is expressed from a U6 promoter as described in this protocol. The score by Moreno-Mateos et al. 52 (CRISPRscan) is best for guides expressed in vitro with a T7 promoter (e.g., for mouse/rat/zebrafish oocyte injections, not discussed further here). On-target scoring is not very reliable, as the Pearson correlation between cleavage and the Doench 2016 score is only ~0.4. Despite this, there is an enrichment for top-scoring guides. For example, for guides in the top 20% of Doench 2016 scores, 40% of them are in the top quartile for efficiency, which is a 1.5-fold enrichment of top quartile guides as compared with random guide selection.
By default, guides in CRISPOR are sorted by guide specificity score and off-targets are sorted by CFD score. The relative importance of off-target specificity versus on-target efficiency depends on the experiment. In some cases, such as when targeting a narrow region, one has limited options, and a guide with low specificity (i.e., many/high-probability off-targets) is the only one available. In this case, more time and effort may be needed to screen for off-target effects. To provide an estimate of the number of off-target sites to test, previous work showed that most off-target cleavages for guides with a specificity of > 50 are detected by screening the 96 predicted off-target sites with the highest CFD scores 9 .
Both off-and on-target scores have been precalculated for coding sequences (and ±200-bp flanking coding sequences) of most common model organisms and are shown when hovering with the computer mouse over a guide in the UCSC Genome Browser track 'CRISPR' in the group 'Genes and Gene Predictions' at http://www.genome.ucsc.edu/cgi-bin/hgTracks?db=hg19. The sequence shown in the UCSC Genome Browser can be sent directly to CRISPOR by selecting 'View -In external tools' in the Genome Browser menu. In the UCSC track, guides are colored by predicted on-target efficiency, whereas they are colored by off-target specificity on crispor.org.
It can be particularly important to use off-target scoring prediction to aid in saturating mutagenesis experiments for sgRNA depletion or dropout 12 . sgRNAs with highly probable off-target sites may deplete/drop out from screens due to cellular toxicity resulting from multiple cleavages, as opposed to a biological effect from mutagenesis of the on-target site.
off-target cleavages [66] [67] [68] [69] [70] [71] [72] . Continued investigation is necessary to more completely understand the rules governing sgRNA efficiency and off-target mutagenesis (see Box 1 for further discussion).
CRISPResso indel analysis can supplement other common analyses, such as analyses of gene expression or protein-level changes. Although CRISPResso is useful for quantifying editing frequency to demonstrate that editing has successfully occurred and demonstrates the full indel spectrum (substitutions, insertions, and deletions), it is often helpful to perform other techniques to assess for changes beyond genomic DNA (gDNA) for further evaluation (i.e., gene expression or protein-level changes).
Experimental design
Target identification and nuclease choice. CRISPR genome-editing experiments require appropriate target identification to fit experimental objectives, which can include functional analysis of gene-or noncoding sequence (e.g., enhancers, CCCTC-binding factor (CTCF), or other transcription factor binding sites). Gene knockout is usually accomplished by targeting exonic sequences, but it can also be achieved through promoter disruption. Gene knockout is often complicated by alternative splicing and/or expression of multiple isoforms for a given gene of interest. It is difficult to predict the relevant isoform without prior knowledge; however, it is often possible to target exonic sequence common to all isoforms or to design sgRNAs targeting unique isoforms to aid in the identification of a relevant/functional isoform. In the case of gene families, conserved domains can be identified for disruption 37 . Although exon targeting toward the 5´ end of the gene has been shown to be more effective for functional disruption than targeting the 3´ end 50 , it is also possible to target functional protein domains. In this case, even in-frame mutations frequently disrupt protein function 73 . Similar considerations can be applied to CRISPR interference (CRISPRi) or CRISPR activation (CRISPRa) approaches; however, CRISPRi/CRISPRa require sgRNA targeting in close proximity to the transcriptional start site for maximal repression/activation 17, [74] [75] [76] [77] [78] [79] [80] ; CRISPRi/CRISPRa approaches are not the focus of this protocol. For further discussion and a protocol for CRISPRa approaches, refer to Joung et al. 20 .
Once target(s) have been identified, it is necessary to determine whether the experiment will be arrayed or pooled. Arrayed experiments are useful when a target can be mutagenized by one sgRNA (e.g., a transcription factor binding motif and gene knockout via exon mutagenesis) (Fig. 1) , whereas pooled screen experiments are useful when a target(s) requires > 1 sgRNA for mutagenesis (Fig. 2) . Both arrayed and pooled experiments are described in this protocol, as arrayed experiments are typically required to validate the results of pooled experiments. As with arrayed experiments, the first step of pooled experiments is target identification. This can include targeting a single locus with multiple sgRNAs (e.g., saturating mutagenesis (so-called tiling sgRNA) experiments) 11, 12, 18 , targeting multiple loci by saturating mutagenesis (e.g., saturating mutagenesis of multiple DHSs) 11, 12 , and gene-targeted pooled screens (e.g., targeting multiple genes with multiple sgRNAs per gene) [14] [15] [16] [17] . In addition, libraries combining gene-based targeting and saturating mutagenesis approaches can also be designed. Experimental designs and workflows in this protocol are summarized in Figure 3 . Finally, each CRISPR nuclease offers a unique PAM sequence with varying frequency of occurrence in the genome depending on the location of targeting such as exons, introns, promoters,
Box 2 | Optimization of parameters for CRISPResso analysis
CRISPResso allows many parameters to be set/adjusted based on the desired analysis to be performed. Details on all the parameters are available in the online help section (http://crispresso.rocks/help). Here, we discuss the key parameters that can significantly affect the quantification.
amplicon sequence (-a) (required; Step 83): This is the sequence expected to be observed without any edits. The sequence must be reported without adapters and barcodes. sgrna sequence (-g) (optional; Step 83): This is the sequence of the sgRNA used, and it should be a subsequence of the amplicon sequence (or its reverse complement). Although this parameter is optional, it is required to specify it to enable the window mode (see the parameter --window_size in order to reduce false positives in the quantification). It is important to remember that the sgRNA must be input as the sgRNA sequence (usually 20 nt) immediately upstream of the PAM sequence for Cas9 species (supplementary table 1). For other nucleases, such as Cpf1, enter the sequence (usually 20 nt) immediately downstream of the PAM sequence and explicitly set the cleavage offset (see the parameter: --cleavage_offset).
coding sequence (-c) (optional; Step 83): The subsequence of the amplicon sequence covering one or more coding sequences. Without this sequence, frameshift analysis cannot be performed (Step 83).
Window size (-w) (optional; Step 83): This parameter allows for the specification of a window(s) in bp around each sgRNA to quantify indels. This can help limit sequencing/amplification errors and/or non-editing polymorphisms (e.g., SNPs) from being inappropriately quantified by CRISPResso's analysis. The window is centered on the predicted cleavage site specified by each sgRNA. Any indels that do not overlap and/or substitutions that are not adjacent to the window are excluded from analysis. A value of 0 will disable this filter (default: 1).
cleavage offset (--cleavage_offset) (optional; Step 83): This parameter allows for the specification of the cleavage offset to use with respect to the provided sgRNA sequence. The default is -3 and is suitable for S. pyogenes Cas9. For alternative nucleases (supplementary table 1), other cleavage offsets may be appropriate. For example, set this parameter to 1 if using Cpf1. average read and single-bp quality (--min_average_read_quality and --min_single_bp_quality) (optional; Step 83): These parameters allow for the specification of the minimum average quality score or the minimum single-bp score for inclusion of a read in subsequent analysis. The scale used is Phred33 (default: 0, minimum: 0, and maximum: 40) 89 . The PHRED score represents the confidence in the assignment of a particular nucleotide in a read. The maximum score of 40 corresponds to an error rate of 0.01%. This average quality of a read is useful to filter out low-quality reads. More-stringent filtering can be performed by using the single-bp quality; any read with a single-bp quality below the threshold will be discarded. A reasonable value for this parameter is > 20.
Identity score (--min_identity_score) (optional; Step 83): This parameter allows for the specification of the minimum identity score for the alignment (default: 60.0). For a read to be considered properly aligned, it should pass this threshold. We suggest lowering this threshold to < 50.0 only if large insertions or deletions are expected in the experiment ( > 40% of the amplicon length) (Step 83).
exclude ends of the read (--exclude_bp_from_left and --exclude_bp_from_right) (optional; Step 83): Artifacts are sometimes present at the ends of the reads due to imperfect adapter trimming or a drop in quality scores. For example, if the ends of reads appear to show indels or appreciable editing frequencies, this may be due to sequencing artifacts, as opposed to true indels from genome editing. Therefore, to exclude these regions at the ends of reads, these parameters allow for the exclusion of a few bp from the left and/or right of the amplicon sequence during indel quantification (default: 15) (Step 83).
trimming of adapters (--trim_sequences) (optional; Step 83): This parameter enables the trimming of Illumina adapters with Trimmomatic (default: False). For custom adapters, the user can customize the Trimmomatic execution using the parameter --trimmomatic_options_string (check the Trimmomatic manual for more information on the different flags and options: http://www.usadellab.org/cms/uploads/supplementary/Trimmomatic/TrimmomaticManual_V0.32.pdf) 90 . It is important to check with your sequencing facility to determine whether the reads were trimmed for adapters or not. If this is not possible, we suggest using the software FASTQC to determine whether reads were already trimmed (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). To perform this analysis, open a terminal and type fastqc. This command will open the main software window. After opening the FASTQ file(s) to analyze with FASTQC, a graphical report will be automatically generated. In the graphical report, find the section 'Adapter content' . If the reads are not properly trimmed, the adapter used will be reported. If a custom adapter was used, find the section 'Overrepresented sequences' instead, where all the sequences that are present in more than 0.1% reads are reported. A subsequence present in more than 10% of the reads is usually an indication that the reads were not properly trimmed. An example of FASTQC report is available here: http://www.bioinformatics.babraham.ac.uk/projects/fastqc/RNA-Seq_fastqc.html#M9. DHSs, enhancers, or repressed regions 12, 65 . The optimal nuclease can be chosen based on the density of available PAMs (e.g., for saturating mutagenesis) or proximity of PAMs to a particular genomic position (e.g., for transcription factor binding motifs) (Supplementary Table 1 ). Finally, high-fidelity nucleases (e.g., HypaCas9, SpCas9-HF1, and eSpCas9) can be used to minimize the probability of off-target mutagenesis [81] [82] [83] .
Positive, negative, and editing controls for arrayed and pooled screen CRISPR experiments. Positive and negative controls are essential for both arrayed and pooled screen experiments. Positive controls are generally experiment-specific; however, some widely used positive controls when performing experiments to identify novel essential genes or when performing dropout ('depletion') screens include targeting of known essential genes (e.g., ribosomal genes and housekeeping genes) (see Box 4 for further discussion of dropout screens). When targeting noncoding sequences for the effects on gene expression, one possible positive control is targeting of exonic sequences 11, 12 .
Negative controls typically take the form of nontargeting controls, which are sgRNAs without any perfect matches in a given genome and with low potential for cleavage at genomic loci with imperfect matches (selected by minimization of sites with few mismatches, which is similar to minimizing off-target effects for targeted sgRNA). Nontargeting controls are genome build-, species-, and PAM-specific (unless designed to be compatible with multiple genomes and/or PAMs). Other options for negative controls include targeting a safe harbor locus such as AAVS1 or a gene/region known to have no effect on cellular function or the phenotype of interest. Nontargeting sgRNA can be generated 'by hand' via a guess-and-check approach to ensure no genomic matches (and minimal sites with few mismatches) or can be designed using previously published tools 12 . For both positive and negative controls, one sgRNA is often used for an arrayed experiment and multiple sgRNAs are often used for pooled screen experiments, oftentimes comprising 1-5% of the total number of sgRNAs in the library (see Box 4 for further discussion) 11, 12 .
An editing control can also be included to ensure proper functioning of the CRISPR reagents, particularly nuclease function (see Boxes 3 and 4 for further discussion). One possibility is to include a construct that expresses GFP together with an sgRNA targeting GFP to assess for functional Cas9 expression by flow cytometry 12, 50 . This is particularly informative when using cell lines with stable Cas9 expression and can be helpful for troubleshooting low or absent editing rates. Typically, only one reporter system/sgRNA to serve as an editing control is needed for both arrayed and pooled experiments. Synthesis of individual or multiple pooled sgRNA libraries. After designing relevant sgRNAs, CRISPOR automates the design of full-length oligonucleotides for pooled screen applications such as saturating mutagenesis (Step 1A and 1C) and gene-targeted libraries generated from a gene list (Step 1B). Barcodes allow for oligonucleotides for multiple unique libraries to be synthesized on the same programmable microarray (Steps 16 and 17), which reduces cost by avoiding purchase of multiple microarrays for multiple libraries. Specifically, the barcodes offer the ability for individual PCR amplification of unique libraries from a single batch of oligonucleotides synthesized on the same microarray. The number of libraries that can be included on a single programmable microarray is limited by the microarray's oligonucleotide capacity; however, there is theoretically no limit to the number of possible
Box 3 | Technical and experimental considerations for performing an arrayed CRISPR genome-editing experiment
Here are some practical guidelines for executing an arrayed CRISPR experiment. An experimental schematic can be found in Figure 1 and an example workflow in Figure 3 :
Generation of cells with stable crIspr nuclease expression: For cell lines, it is convenient to generate lines with stable CRISPR nuclease expression for arrayed experiments. This can be accomplished by transducing cells with a lentiviral CRISPR nuclease with subsequent selection for transduced cells, such as the usage of lentiviral Cas9 with blasticidin resistance (the focus of the remainder of the discussion here will be on the usage of S. pyogenes Cas9; however, the same principles apply to other CRISPR nucleases, including Cpf1). It is recommended that a 'kill curve' be created to determine the optimal concentration of blasticidin for the cells used before beginning the experiment. It is also important to determine the duration of selection required to complete cell death by blasticidin, as assessed by cell viability over time with blasticidin selection. Stable expression of Cas9 can be confirmed via western blot. Alternatively, stable expression can be confirmed by assessing Cas9 function using a reporter system, such as the previously described constructs that provide GFP and an sgRNA targeting GFP to assess for functional Cas9 through flow cytometry (MATERIALS) 12, 50 . It is possible to screen for clones with high Cas9 expression and/or high Cas9 activity, as assessed by a reporter; however, it is not required. If stable Cas9 expression cannot be generated, such as with usage of primary cells with limited culture duration, cotransduction of Cas9 and sgRNAs can be performed with double selection (blasticidin for Cas9 and puromycin for sgRNA). Cotransduction can occur simultaneously or can occur on back-to-back days. Selection by blasticidin and/or puromycin is typically performed 24-48 h after transduction.
arrayed sgrna experiment execution: Unlike a pooled screen experiment as described in box 4, copy number (i.e., number of viral integrants per cell) may not be an important consideration for many experiments, as only one sgRNA is being used. Therefore, it may be important only for certain applications for cells to have one copy of the sgRNA (i.e., comparing sgRNA efficiencies) or have a mixture of ≥1 copy (e.g., experiments aiming to simply have maximal editing frequency). Therefore, lentiviral transduction of Cas9-expressing cells can occur at low multiplicity (goal transduction rate of 30-50%) to ensure single integrants (i.e., one sgRNA per cell) [91] [92] [93] . Alternatively, lentiviral transduction of Cas9-expressing cells can occur at high multiplicity (transduction rate > 50%) to obtain a higher rate of transduced cells with a resulting heterogeneous mix of sgRNA copy number. For an arrayed experiment with one sgRNA, multiple integrants per cell do not result in 'passenger' sgRNAs and associated false positives. Lentiviral transduction efficiency is affected by cell density, volume, incubation time, and multiplicity of infection (MOI). Therefore, it is important to keep all of these factors constant to ensure consistent lentiviral transduction rates. Notably, this underscores the importance of aliquoting lentivirus to ensure consistent lentiviral titer, as titer is decreased by freeze-thaw cycles (see Steps 60 and 71) . A decrease in cell density, a decrease in media volume, and an increase in MOI will all increase transduction rates. Similar to blasticidin, it is recommended to create a kill curve and determine the duration of selection. Longer exposure to the CRISPR/Cas9 reagents results in increased editing rates 14 . A reasonable experiment duration is 1-2 weeks 14 ; however, this may vary based on the experimental system used. It is possible to use a Cas9 nuclease activity reporter as described above to more accurately determine when editing has plateaued in the experimental system. At the end of the experiment, cell pellets can be made to proceed with deep sequencing (Steps 73-82).
enhancment of lentiviral transduction:
Multiple methods exist to enhance lentiviral transduction. Reagents such as polybrene, rapamycin, protamine sulfate, and prostaglandin E2 have been shown to enhance lentiviral transduction rates 94 . In addition, lentiviral spin-infection (centrifugation during transduction) can enhance transduction rates 95 . These types of methodologies to enhance lentiviral transduction can be useful to reduce the amount of lentivirus required for experiments, can help achieve the desired transduction rates in the setting of low lentiviral titer, and can increase efficiency for difficult-to-transduce cells. It is important to determine whether any of these reagents/methods lead to cellular toxicity. 
Box 4 | Technical and experimental considerations for performing a pooled CRISPR genome-editing experiment
Here are some practical guidelines for executing a pooled screen using an sgRNA library with 1,000 sgRNAs with a goal of 1,000× representation of the sgRNA library. An experimental schematic can be found in Figure 2 and an example workflow in Figure 3 :
Generation of cells with stable crIspr nuclease expression: For cell lines, it is convenient to generate lines with stable CRISPR nuclease expression for pooled experiments. This can be accomplished by transducing cells with a lentiviral CRISPR nuclease, with subsequent selection for transduced cells, such as the usage of lentiviral Cas9 with blasticidin resistance (the focus of the remainder of the discussion here will be on the usage of S. pyogenes Cas9; however, the same principles apply to other CRISPR nucleases, including Cpf1). It is recommended that a kill curve be created to determine the optimal concentration of blasticidin for the cells used before beginning the experiment. It is also important to determine the duration of selection required to complete cell death by blasticidin. Stable expression of Cas9 can be confirmed via western blot. Alternatively, stable expression can be confirmed by assessing Cas9 function using a reporter system, such as the previously described constructs that provide GFP and an sgRNA targeting GFP to assess for functional Cas9 through flow cytometry (MATERIALS) 12, 50 . It is possible to screen for clones with high Cas9 expression and/or high Cas9 activity, as assessed by a reporter; however, it is not required. If stable Cas9 expression cannot be generated, such as with usage of primary cells with limited culture duration, cotransduction of Cas9 and sgRNAs can be performed with double selection (blasticidin for Cas9 and puromycin for sgRNA). Cotransduction can occur simultaneously or can occur on back-to-back days. Selection by blasticidin and/or puromycin is typically performed 24-48 h after transduction. sgrna library representation: Library representation refers to estimating how frequently each sgRNA in the library is included in the experiment. 1,000× representation of a library suggests that 1,000 cells were transduced by the median sgRNA in the library at the beginning of the experiment. Suboptimal representation may lead to the absence of certain sgRNAs from the screen experiment and thus can cause sgRNAs to appear falsely depleted from the experiment. The desired level of representation may reflect the expected uniformity of genome-editing outcome and biologic phenotype, as well as the distribution of sgRNA abundance within the library. For example, true-positive sgRNAs expected to have uniform genetic and biological effect and narrowly distributed abundance may require lower representation to be accurately identified as hits. To represent a 1,000 sgRNA library at 1,000×, 1 million cells must be transduced (1,000 sgRNAs × 1,000 cells each = 1,000,000 cells).
transduction at low multiplicity: Lentiviral transduction of Cas9-expressing cells at low multiplicity ensures single integrants (i.e., one sgRNA per cell) [91] [92] [93] . As such, the goal transduction rate is 30-50%. Transduction rates > 50% increase the risk of multiple integrants per cell, which can result in 'passenger' sgRNAs and associated false positives. Lentiviral transduction efficiency is affected by cell density, volume, incubation time, and MOI. Therefore, it is important to keep all of these factors constant to ensure consistent lentiviral transduction rates. Notably, this underscores the importance of aliquoting lentivirus to ensure consistent lentiviral titer, as titer is decreased by freeze-thaw cycles (Steps 60 and 71). The example screen requires transduction of 1,000,000 cells to represent the sgRNA library at 1,000×; however, this refers to the number of transduced cells. As the transduction rate must be between 30 and 50%, this requires using 2,000,000-3,333,333 cells at the beginning of the experiment, which will be reduced to 1,000,000 cells upon selection by puromycin for successful transductants.
Determination of screen conditions:
For this example, the goal will be a 40% transduction rate. Therefore, the experiment will require 2,500,000 cells (2,500,000 × 0.4 = 1,000,000). As previously described, lentiviral transduction efficiency is affected by cell density, volume, incubation time, lentiviral titer, and MOI. Constant titer will be assumed due to appropriate lentivirus aliquoting (Steps 60 and 71). Increasing media volume results in lower transduction. Therefore, it is useful to limit the amount of media. In addition, it can be simpler to perform the transduction in 'parts' (e.g., ten separate transductions of 250,000 cells). A reasonable approach would include transducing ten wells in a 24-well plate of 250,000 cells in 500 µl of medium (cell density of 500,000 cells/ml). The use of a 24-well plate and the cell density of 500,000 cells/ml are reasonable approaches; however, these may need to be optimized for the cells used for study and/or experimental goals. Transductions should be performed at different MOIs to determine the MOI needed to achieve the goal transduction rate of 40%.
enhancement of lentiviral transduction:
Multiple methods exist to enhance lentiviral transduction. Reagents such as polybrene, rapamycin, protamine sulfate, and prostaglandin E2 have been shown to enhance transduction rates 94 . In addition, lentiviral spin-infection (centrifugation during transduction) can enhance transduction rates. These types of methodologies to enhance lentiviral transduction can be useful to reduce the amount of lentivirus required for experiments, can help achieve the desired transduction rates in the setting of low lentiviral titer, and can increase efficiency for difficult-to-transduce cells. It is important to determine whether any of these reagents/methods lead to cellular toxicity. If a reagent/method is used, it should be used for all transduction samples. In addition, the reagent/method should be used when determining the MOI to achieve the goal transduction rate (40% in this case).
pooled sgrna screen experiment execution: For this example, it will be assumed that an MOI of 1 results in a 40% transduction rate. To perform the screen, ten wells in a 24-well plate with 250,000 cells in 500 µl of medium (cell density of 500,000 cells/ml) are transduced at an MOI of 1. 24 h after transduction, the ten wells can be pooled into one larger well or flask. Before selection for successful transduction, it is useful to remove a subset of cells from the pooled transductions to determine transduction efficiency to ensure that ~40% transduction was empirically achieved. A reasonable approach would include pooling all ten wells together for a total of 2,500,000 cells in 5 ml of medium 24 h after transduction. ~25,000-50,000 cells can be removed from this 5-ml cell mixture to be used to determine transduction rate by splitting the cells into with and without puromycin conditions to confirm the transduction rate by cell counts post selection. After removal of ~25,000-50,000 cells, puromycin selection should be initiated on all the cells barcodes that can be used (and thus no limit to the number of libraries that can be generated from a single pool of oligonucleotides). Barcodes for ten libraries are provided in Supplementary  Table 2 . To create additional or new barcodes, generate 10-13 bp of sequence distinct from the sequences to be amplified and the other barcodes used. It is also important to ensure that the barcode results in a primer melting temperature (Tm) compatible with the lsPCR1 reaction (Step 19; see Supplementary Table 3 for examples). Homologous sequence to the lentiGuide-Puro plasmid is required because batch sgRNA library cloning is performed using Gibson assembly (Steps 27 and 28), which relies on homologous flanking sequence for successful cloning.
Sequencing of arrayed experiments and pooled screens. Sanger sequencing is initially required to confirm successful cloning of an individual sgRNA for an arrayed experiment using a U6 sequencing primer (5′-CGTAACTTGAAAGTATTTCGATTTCTTGGC-3′ (ref. 62)). For a pooled screen experiment, deep sequencing is required to confirm successful library cloning.
Deep sequencing can be used to analyze editing outcomes for arrayed experiments. In contrast, deep sequencing is typically required to analyze pooled screen experiments. The choice for appropriate deep-sequencing platform (e.g., MiSeq or HiSeq) should include consideration of the required number of reads for the experiment as well as cost. For an arrayed experiment for indel enumeration/analysis by CRISPResso (Step 83), the number of reads needed to adequately represent a locus may vary widely based on experimental goals; however, > 1,000 reads at a given locus is reasonable. For a pooled sgRNA library experiment, 100-1,000× coverage of the number of sgRNAs in the library is reasonable. The desired read length should be chosen on the basis of the length of the amplicon generated by the primers used in Step 75. Once the deep-sequencing platform has been selected, submit barcoded samples for deep sequencing (Step 82; these represent different barcodes than those described in the 'Synthesis of individual or multiple pooled sgRNA libraries' section).
Amplicon length should be compatible with the read length as described above. 100-and 200-bp amplicons are reasonable for paired-end deep sequencing with 75-or 150-bp reads, respectively. Because sequencing quality is lower toward the end of the reads, there must be some overlap of read pairs to allow reliable merging. For example, for a 200-bp amplicon, it is suggested to use 125-to 150-bp reads in order to have sufficient overlap. Some considerations for determining amplicon length include the cost of sequencing for a given read length, the size in base pairs of the region to be sequenced, and the length of reliable sequencing (due to unreliable sequence at read ends). If an amplicon length is too short, it may result in inadequate coverage of the target region, as well as miss larger indels. By contrast, if the amplicon is longer than twice the read length, no overlap will exist between reads, making the merging steps of paired-end reads impossible.
Box 4 | Technical and experimental considerations for performing a pooled CRISPR genome-editing experiment (continued)
in the well/flask. It is recommended that a kill curve be created to determine the optimal concentration of puromycin for the cells used before beginning the screen experiment. It is also important to determine the duration of selection required to complete cell death by puromycin. Longer exposure to the CRISPR/Cas9 reagents results in increased editing rates 14 . A reasonable screen duration is 1-2 weeks 14 ; however, this may vary based on the experimental system used. It is possible to use a Cas9 nuclease activity reporter, as described above, to more accurately determine when editing has plateaued. At the end of the experiment, cell pellets can be made in order to proceed with deep sequencing (Steps 73-82).
types of screens: Screens typically rely on either positive or negative selection. Common screen strategies involve determination of enrichment or dropout ('depletion') of sgRNAs. This can be achieved by deep sequencing either the plasmid pool or cells at an early time point in the experiment to serve as the initial time point for comparison. It has been previously shown that there is no difference between using the plasmid pool versus cells from an early time point in the experiment for this purpose 14, 96 . Deep sequencing of samples at the end of the experiment can then be compared with that at this initial time point. The sgRNA presence can be determined by enumerating sgRNAs using CRISPRessoCount (Figs. 2 and 3 , Steps 84-86). Using enrichment/dropout strategies, screens can be performed for applications such as drug/toxin resistance/susceptibility or FACS-based selection (using antibody or cell reporter). A summary of representative published screens is provided in Joung et al. 20 . Sharing disk volumes with Docker By default, Docker containers cannot share data with the machine on which they run. For this reason, it is necessary to map local folders to folders inside the Docker container. Mapping allows the container to read the input data files to process/write the output files into a folder on the disk of the local machine. First, it is necessary to check whether Docker has permission to access the disk(s) on your machine where analysis data are to be stored and processed. By default, any subfolder within your home directory is automatically shared; however, this behavior may change with future versions of Docker. Check that the drive(s) you want to be available to the container is/are selected in the 'Settings…/ Shared Drives' panel ( Supplementary Fig. 1a ).
MaterIals

REAGENTS
To map a local folder (i.e., a folder on the local disk) to a container folder, Docker has a special option with this syntax:
-v local_folder:container_folder You can specify this option multiple times if it is necessary to map more than one folder. In our examples, the folders to map are all subfolders of the home folder of the user 'user' , i.e., /home/user/. In addition, some of the Docker commands will be used with the option -w /DATA to specify the working directory (i.e., where the command will be executed) to allow for the use of relative paths and to shorten the commands. Allocation of memory for Docker containers It is necessary to allocate enough memory to the container. The default assigned by Docker may depend on the version and on the machine on which it is run. To run the CRISPOR/CRISPResso containers, we suggest assigning Docker 6-8 GB of RAM. For analysis involving large sequences or many sites, it may be necessary to increase the amount of allocated memory under the 'Settings…/ Advanced' panel (Supplementary Fig. 1b) . The execution may halt with an error if enough memory is not allocated to the container (e.g., with '/bin/bash: line 1: 14 Killed/crisporWebsite/bin/Linux/bwa bwas w'). In this instance, the memory allocated to the Docker container is not sufficient to run CRISPOR, and the process is terminated. Therefore, increase the memory as discussed above and run the same command again.
CRISPResso installation
The CRISPResso utility can be used for analysis of deep-sequencing data of a single locus/amplicon on a local machine or proprietary server, using a command-line version or a webtool freely available at http://crispresso.rocks/. The webtool version of CRISPResso does not require installation. For installation of the command-line version of CRISPResso or installation of CRISPResso with Docker, see the instructions below.
Installation of the command-line version of CRISPResso. To install CRISPResso on a local machine, it is necessary to install some dependencies before running the setup script. Download and install Anaconda Python 2.7, following the instructions at this link:
http://continuum.io/downloads. Open a terminal and type conda config --add channels r conda config --add channels defaults conda config --add channels conda-forge conda config --add channels bioconda conda install CRISPResso fastqc Close the terminal and open a new one; this will set the PATH variable. Now, you are ready to use the command-line version of CRISPResso.
If you have installed an old version of CRISPResso, please remove it with the following command to avoid conflicts:
rm -Rf /home/user/CRISPResso_dependencies Installation of CRISPResso with Docker. To install CRISPResso with Docker, it is necessary to verify that Docker is installed before running the setup script (see 'Installation of Docker' within the 'Equipment Setup' section). After verification of Docker installation, type the following command:
docker pull pinellolab/crispor_crispresso_nat_prot Check whether the container was downloaded successfully by running the command docker run pinellolab/crispor_crispresso_nat_prot CRISPResso --help If CRISPResso was properly installed, you will see the Help for the command-line version of CRISPResso. proceDure sgrna design using crIspor • tIMInG 1-4 h 1| Design sgRNAs from a single genomic locus using the CRISPOR webtool by following option A. sgRNAs can be selected manually from the CRISPOR output using on-and off-target predictions (box 1). Alternatively, follow option B for the 'CRISPOR Batch' gene-targeting assistant webtool for gene-targeted pooled library generation from a gene list. If multiple genomic loci are required for sgRNA design or the command-line version is preferred, use option C for the command-line version of CRISPOR.  crItIcal step CRISPOR does not offer the ability to design repair templates for HDR experiments. If the experimental design requires a repair template, other protocols can provide further instruction 62 . (ii) Input the target DNA sequence. The webtool requires a sequence input (< 2 kb) or genomic coordinates.  crItIcal step The input sequence must be a genomic sequence as opposed to a cDNA sequence, as the latter can include sequences that are not in the genome due to splicing. You can obtain genomic sequences using a website such as the UCSC Genome Browser (https://genome.ucsc.edu, click on 'View -DNA' after searching for a gene or genomic region) or Ensembl (http://www.ensembl.org, click on 'Export data -Text' after searching for a gene or genomic region). From the UCSC Genome Browser, the current sequence in view can be sent directly to CRISPOR via the menu entry 'View -In external tools' . ? troublesHootInG (iii) Select the relevant genome assembly (e.g., hg19, mm9) and PAM sequence for the nuclease (e.g., NGG for Streptococcus pyogenes Cas9).  crItIcal step It is important to pick the appropriate assembly to be consistent with the genomic coordinates of the DNA sequence provided in Step 1A(ii) and for accurate prediction of off-target sites. docker pull pinellolab/crispor_crispresso_nat_prot (ii) Verify that the container was downloaded successfully by running the following command:
docker run pinellolab/crispor_crispresso_nat_prot crispor.py (iii) Obtain the CRISPOR assembly identifier of the genome (e.g., hg19 or mm9). If you are unsure, the full list of assemblies is available at http://crispor.tefor.net/genomes/genomeInfo.all.tab. This protocol uses 'hg19' in its examples; however, this should be switched to the relevant identifier for the assembly of interest as appropriate. (iv) Execute the following commands to download the relevant pre-indexed genome in the folder created in the previous step. Here, we are assuming that the user will store the pre-indexed genomes in the folder /home/user/ crispor_genomes. Table' parameter will offer different options depending on the chosen 'Track' .
Step 1C(viii-xii) is based on the example entry from
Step 1C(vii): The sgRNA sequences will be written to the file crispor_output.tsv and four files for each sequence ID in the FASTA file will be created as in the web version in the folder /home/user/crispor_data/ (see table 2 for output files). (xiv) To select a subset of sgRNAs from the file REGION_1_satMutOligos.tsv as generated in Step 1A(iv) or 1C(xiii) ( 7| Add 1 µl of TSAP to dephosphorylate the reaction for 15 min at 37 °C, followed by heat inactivation for 15 min at 74 °C.
8| Perform gel purification of the Esp3l-digested/dephosphorylated lentiGuide-Puro plasmid. See MATERIALS for gel purification kit and follow the manufacturer's instructions. For further information on gel purification, refer to this previously published protocol 84 .
9| Determine the concentration of the Esp3l-digested/dephosphorylated lentiGuide-Puro plasmid after gel purification using a UV-visible spectrophotometer (e.g., NanoDrop) or other equivalent method, following the manufacturer's instructions. 
11|
Heat-shock-transform the ligation reaction into stable competent E. coli by incubating samples at 42 °C for 45 s, followed by a 10-min incubation on ice. Add 250 µl of SOC medium and incubate at 37 °C with 250-r.p.m. shaking for 1 h. Use of recombination-deficient E. coli is important to minimize recombination events of repetitive elements in lentiviral plasmid (e.g., long terminal repeats). For more information about performing heat-shock transformation of competent E. coli, refer to previously published protocols 85, 86 .
12| Plate the transformation product from
Step 11 on a 10-cm ampicillin-resistant (0.1 mg/ml ampicillin) agar plate. Incubate at 32 °C for 14-16 h. It is recommended that transformation products be incubated at 32 °C to reduce recombination between lentiviral long terminal repeats, but incubation at 37 °C can also be performed.
13|
Picking three to five colonies is reasonable for individual incubation of each colony in 2 ml of ampicillin-resistant (0.1 mg/ml ampicillin) LB medium at 32 °C for 14-16 h with shaking at 250 r.p.m. It is recommended that transformation products be incubated at 32 °C to reduce recombination between lentiviral long terminal repeats, but incubation at 37 °C can also be performed.
? troublesHootInG 14| Perform mini-scale plasmid preparation of each 2-ml culture from Step 13 (see MATERIALS for a mini-scale plasmid preparation kit; follow the manufacturer's instructions).  pause poInt Successfully cloned sgRNA plasmids can be stored long term (years) at − 20 °C before creating lentivirus (Steps 49-71).
15| Sanger-sequence each colony-derived plasmid with the U6 sequencing primer to identify correctly cloned plasmids (see 'Experimental design' section for U6 primer sequence) 62 . Subsequent midi-or maxi-scale plasmid preparation may be required for lentivirus production (Steps 49-71). 
17|
Order the designed DNA oligonucleotides on a programmable microarray (MATERIALS).
18|
Obtain the resuspended oligonucleotides for use as the template for the PCR reaction in Step 19. The concentration will be determined by the manufacturer, so refer to the manufacturer for identifying the concentration.  pause poInt Oligonucleotide pools can be stored at − 20 °C for short-term storage (months to years) and at − 80 °C for long-term storage (years).
19|
Set up the barcode-specific PCR to amplify using the barcode-specific primers (supplementary  crItIcal step The number of PCR cycles should be limited to reduce PCR bias. It is difficult to predict the required number of cycles for a given library. Therefore, it is important to perform multiple PCRs with different numbers of cycles to empirically determine the optimal number of cycles.  pause poInt The PCR product can be stored for multiple days at 4 °C in the thermocycler at the end of the PCR program. Long-term storage (months to years) should be at − 20 °C.
21| Run a fraction (1-5 µl of the 50-µl PCR reaction from
Step 20) of each lsPCR1 product with a different number of PCR cycles on a 2% (wt/vol) agarose gel. Analyze the gel to determine if the products occur at the expected size of ~100 bp (supplementary Fig. 2a) . If the bands run at the expected size, determine the minimal number of PCR cycles required to produce a visible band (supplementary Fig. 2a ). For example, 15 cycles would be used based on the gel presented in supplementary Figure 2a ; however, it may be possible to reduce the cycle number even further (i.e., another experiment with 5 and 10 PCR cycles). Use the remaining reaction volume for the cycle number chosen for Step 22 based on the gel from this step.
22|
Using nuclease-free water, dilute the lsPCR1 reaction chosen in Step 21 1:10.
23| Set up 'Library Synthesis PCR2' (herein referred to as lsPCR2) with the universal lsPCR2 primers listed in supplementary table 4. lsPCR2 amplification removes the library-specific barcodes and adds a sequence homologous to the lentiGuide-Puro plasmid for Gibson assembly-based cloning of the library.  crItIcal step It is important to use a proofreading DNA polymerase to minimize introduction of PCR errors. 24| Perform lsPCR2 using the same cycling conditions and multiple cycle numbers as Step 20 .  pause poInt The PCR product can be stored for multiple days at 4 °C in the thermocycler at the end of the PCR program. Long-term storage (months to years) should be at − 20 °C.
25|
Run lsPCR2 products on a 2% (wt/vol) agarose gel to determine whether the products occur at the expected size of ~140 bp (supplementary Fig. 2b ). Choose the sample with the minimal number of PCR cycles that produces a visible band in order to minimize PCR bias (supplementary Fig. 2b ). For example, 15 cycles would be used based on the gel presented in supplementary Figure 2b ; however, it may be possible reduce cycle number even further (i.e., another experiment with 5 and 10 PCR cycles).
26|
Gel-purify the ~140-bp band. See MATERIALS for gel purification kit and follow the manufacturer's instructions. For further information on gel purification, refer to this previously published protocol 84 .  crItIcal step If synthesizing multiple libraries simultaneously, leave empty lanes between different samples during gel electrophoresis to minimize the risk of sample contamination during gel purification.
27|
Set up a Gibson assembly reaction using gel-purified Esp3l-digested/dephosphorylated lentiGuide-Puro plasmid from Steps 5 to 9:
Gel-purified lsPCR2 from
Step 26 10 single pipetting up and down will be sufficient). Recovery medium is preferred here; however, SOC medium can be used in its place.  crItIcal step Electroporation is toxic to bacterial cells. Addition of recovery or SOC medium as quickly as possible enhances bacterial cell survival after electroporation.
36|
Transfer the cell mixture from Step 35 (~1 ml) to a culture tube already containing 1 ml of SOC medium.
37|
Shake each culture tube (containing a total of 2 ml of recovery/SOC medium) at 250 r.p.m. for 1 h at 37 °C.  crItIcal step If multiple transformations were set up in Step 32 using the same Gibson assembly reaction mixture, the 2-ml culture mixes generated in Step 37 can be pooled/mixed together so that one set of dilution plates is sufficient for calculation of transformation efficiency (Step 38).
38|
Remove 5 µl from the 2-ml mixture (or 5 µl from a larger volume, if samples were pooled/mixed as described in
Step 37) from Step 37 and add it to 1 ml of SOC medium. Mix well and plate 20 µl of the mixture (20,000× dilution) onto a prewarmed 10-cm ampicillin-resistant (0.1 mg/ml ampicillin) agar plate and then plate the remaining 200 µl (2,000× dilution) onto a separate 10-cm ampicillin-resistant (0.1 mg/ml ampicillin) agar plate. These two dilution plates can be used to estimate transformation efficiency, which will help ensure full library representation of the sgRNA plasmid library. It is reasonable to aim for > 50× representation of the sgRNA library.  crItIcal step Adjust the dilutions as necessary to obtain plates with a colony density that allows for accurate counting of the number of colonies on the 10-cm plates.
39|
Plate the remaining 2-ml transformation mixture (or 2 ml from a larger volume, if samples were pooled/mixed) from
Step 37 onto a prewarmed square 24.5-cm ampicillin-resistant (0.1 mg/ml ampicillin) agar plate using beads to ensure even spreading. Spread the liquid culture until it is largely absorbed into the agar and will not drip when inverted.  crItIcal step If multiple samples were mixed/pooled together in Step 37, it is still important to only plate 2 ml onto each square 24.5-cm ampicillin-resistant agar plate, as volumes > 2 ml may not be fully absorbed into the agar.
40| Invert all three (or more) plates (2,000× dilution plate, 20,000× dilution plate, and square 24.5-cm nondilution plate(s)) from Steps 38 and 39, and grow for 14-16 h at 32 °C. It is recommended to incubate transformations at 32 °C to reduce recombination between lentiviral long terminal repeats, but incubation at 37 °C can also be performed.
41|
Count the number of colonies on the two dilution plates from Step 38. Multiply this number of colonies by the dilution factor (2,000× or 20,000×) and by the increased area of the square 24.5-cm plate (~7.6-fold increase in area) for estimation of the total number of colonies on the square 24.5-cm plate. It is reasonable to aim for > 50× representation of the sgRNA library.
? troublesHootInG 42| Select ~10-20 colonies from the dilution plates (from Step 41) for screening by mini-scale plasmid preparation and subsequent Sanger sequencing (as in Steps 14 and 15) to determine whether the sgRNA library has been PCR-amplified. Given that the oligonucleotides for multiple libraries can be synthesized on the same programmable microarray (Steps 16 and 17), it is important to confirm that the correct library intended for amplification has been obtained. This is also useful for preliminary evaluation of library representation. The expectation is to identify unique sgRNA sequences among all sequenced mini-scale plasmid preparations, given that the probability of obtaining the same sgRNA from a full library of sgRNAs should be low.  crItIcal step This step is intended to offer qualitative re-assurance that library synthesis is proceeding in the expected manner by determining that the correct library has been PCR-amplified and offering an initial assessment of library representation. Ultimately, the deep-sequencing step (
Step 48) provides a more comprehensive assessment of library composition. ? troublesHootInG 43| Pipette 10 ml of LB medium onto each square 24.5-cm plate from Steps 39 and 40 and scrape the colonies off with a cell scraper. The LB medium aids in removal of the colonies from the agar.
44|
Pipette the LB medium/scraped bacterial colony mixture into a preweighed 50-ml tube and repeat the procedure a second time on the same plate with an additional 5-10 ml of LB to maximize removal of bacterial colonies. 62| Add 4-6 ml of 20% (wt/vol) sucrose solution to the bottom of the ultracentrifugation tube to create a sucrose layer (also known as a 'sucrose cushion') below the viral supernatant. This sucrose layer helps to remove any remaining debris from the viral supernatant, as only the high-density viral particles can pass through the sucrose layer to pellet, whereas the low-density debris remains in the supernatant. ? troublesHootInG 63| Add sterile PBS to the top of the ultracentrifuge tube until the final liquid volume within the ultracentrifuge tube is ~2-3 mm from the top.  crItIcal step The volume must be within 2-3 mm of the top of the tube to prevent the tube from collapsing because of the force of ultracentrifugation.
64| Place ultracentrifuge tubes into ultracentrifuge buckets.
65| Weigh all ultracentrifuge buckets containing ultracentrifuge tubes before ultracentrifugation to ensure appropriate weight-based balancing. Use sterile PBS to correct weight discrepancies.
66|
Centrifuge at 100,000g for 2 h at 4 °C in an ultracentrifuge.
67|
Remove ultracentrifuge tubes from ultracentrifuge buckets. The sucrose gradient should still be intact. ? troublesHootInG 68| Discard the supernatant by inverting the ultracentrifugation tube. Allow the inverted ultracentrifuge tube to stand on sterile paper towels to dry for 1-3 min.
? troublesHootInG 69| Revert the ultracentrifugation tube to an upright orientation and add 100 µl of sterile DMEM supplemented with 1% (vol/vol) FBS. with enough lentivirus for one experiment). Aliquots frozen at the same time can be assumed to have the same titer, which can be advantageous for multiple experiments using the same lentivirus.  pause poInt Lentiviruses can be stored at − 80 °C for months. Longer storage will result in a decrease of viral titer.
70|
execution of arrayed or pooled screen experiments • tIMInG 1-2 weeks 72| Perform arrayed or pooled screen experiments. Experiments/screens using lentivirus should be performed as appropriate for the experimental design/objectives and the cells being used for study. Refer to boxes 3 and 4 for discussions about and considerations for performing an arrayed or pooled screen experiment.  pause poInt After experiments/screens have been completed, cell pellets can be stored at − 20 or − 80 °C for weeks to months before processing for deep-sequencing analysis of the samples (Steps 73-82 ).
Deep sequencing of arrayed or pooled screen experiments • tIMInG 1 d 73| Extract gDNA from fresh cell pellets after completion of genome-editing screens/experiments or from frozen pellets from previous experiments. See MATERIALS for genomic DNA extraction kit and follow the manufacturer's instructions.  crItIcal step For arrayed experiments intended for indel analysis by CRISPResso (Step 83), it is recommended to include a non-edited sample from the same cell type. This sample will be a useful negative control when performing CRISPResso indel analysis/enumeration. Specifically, a non-edited sample is useful in regard to optimization of the CRISPResso analysis parameters summarized in box 2. Furthermore, a non-edited sample can be useful in identifying single-nucleotide polymorphisms (SNPs) or other variants present in the cells under study that can confound CRISPResso analysis. If a variant/indel is identified in the non-edited sample, the CRISPResso settings can be altered to account for the variant/indel during CRISPResso indel enumeration (box 2).
74| Determine the concentration of each gDNA sample using a UV-visible spectrophotometer (e.g., NanoDrop) or other equivalent method using the manufacturer's instructions.  crItIcal step The amount of gDNA can vary based on experimental needs for an arrayed experiment and based on the number of sgRNAs in the library for a pooled experiment. On average, a genome from a single cell is ~6.6 pg 88 . Use adequate gDNA to represent the desired number of cells. For an arrayed experiment for indel analysis of a single locus using CRISPResso, > 1,000 cells at a given locus is a reasonable number. For a pooled sgRNA library experiment, 100-1,000× coverage of the sgRNAs in the library is reasonable. For example, 6.6 µg of gDNA is estimated to represent 1 million cells. For a library with 1,000 sgRNAs, 6.6 µg of gDNA would provide 1,000× coverage.
75|
Set up the 'Library Analysis PCR1' reaction (herein referred to as laPCR1). Use lentiGuide-Puro-specific primers (supplementary table 5) to enumerate the sgRNAs present for enrichment/dropout analysis or locus-specific primers to quantitate indels (supplementary table 6). lentiGuide-Puro-specific primers are suggested in supplementary table 5 ; however, other primer pairs to PCR-amplify from the lentiGuide-Puro construct are possible.  crItIcal step It is important to use a proofreading DNA polymerase to minimize introduction of PCR errors.  crItIcal step Optimization of DMSO concentration may be required (typically 1-10% (vol/vol)). 8% (vol/vol) is used in the reaction below.  crItIcal step It is important to sequence the cloned plasmid library as generated in Steps 16-47. Sequencing of the plasmid library allows for confirmation of successful cloning/representation of the library and can be used as an initial time point for a dropout ('depletion') screen (see box 4 for details of this type of screen). Given that plasmids contain many fewer base pairs than a full genome, ≥50 pg of plasmid DNA will be sufficient to represent a pooled plasmid library. 76| Perform multiple cycles (e.g., 10, 15, and 20 cycles) of laPCR1 in a thermocycler as follows. Gradient PCR may be required to determine the optimal annealing temperature (supplementary Fig. 2c ). ? troublesHootInG  pause poInt The PCR product can be stored at 4 °C in a thermocycler at the end of the PCR program for multiple days. Longer-term storage (months to years) should be at − 20 °C.
77|
Run a fraction (1-5 µl of the 50-µl PCR reaction from Steps 75 and 76) of the laPCR1 product with a different number of PCR cycles on a 2% (wt/vol) agarose gel.  crItIcal step The number of PCR cycles should be limited to reduce PCR bias. It is difficult to predict the required number of cycles for a given library. Therefore, it is important to perform multiple PCRs with different cycle numbers to empirically determine the optimal number of cycles. ? troublesHootInG 78| Set up 'Library Analysis PCR2' (herein referred to as laPCR2) using the barcode-specific primers (supplementary tables 7 and 8). Each sample will need a unique Illumina Nextera index to allow demultiplexing of multiple samples sequenced together. Set up two PCRs for each sample.  crItIcal step Two separate 10-µl reactions are performed, as opposed to a single 20-µl reaction, to minimize PCR bias. 79| Perform laPCR2 using the same cycling conditions and multiple cycle numbers as in Step 76.  crItIcal step The number of PCR cycles should be limited to reduce PCR bias. It is difficult to predict the required number of cycles for a given library. Therefore, it is important to perform multiple PCRs with different cycle numbers to empirically determine the optimal number of cycles.  pause poInt The PCR product can be stored at 4 °C in a thermocycler at the end of the PCR program for multiple days. Longer-term storage (months to years) should be at − 20 °C.
80|
Combine both 10-µl reactions from the same sample for a total volume of 20 µl. Run laPCR2 products on a 2% (wt/vol) agarose gel to determine whether the products occur at the expected size (expected size varies based on primers used in laPCR1). Choose the sample with the minimal number of PCR cycles that produces a visible band in order to minimize PCR bias (supplementary Fig. 2d ). For example, 20 cycles would be used based on the gel presented in supplementary Fig. 2d ; however, it may be possible to reduce the cycle number even further (i.e., another experiment with 5, 10, and 15 cycles). Then gel-purify the relevant band of the expected size.  crItIcal step Leave empty lanes between different samples to minimize the risk of sample contamination during gel purification. 
82|
Sequence the libraries on a MiSeq, HiSeq, or equivalent sequencing platform (see 'Experimental design' for details).  crItIcal step It can be useful to discuss experimental goals with the sequencing facility or individual performing the sequencing prior to sequencing samples to help ensure that the desired number of reads are obtained to adequately represent the sequenced locus/loci or sgRNA library.
crIspresso analysis of deep-sequencing data • tIMInG 10-120 min 83| The CRISPResso utility can be used for analysis of deep-sequencing data of a single locus/amplicon on a local machine or proprietary server, using a command-line version or a webtool freely available at http://crispresso.rocks/. Installation instructions are provided in the 'Equipment Setup' section for command-line and Docker versions. No installation is required for the webtool. The following step will present detailed instructions for workflows using the webtool (option A), commandline (option B), or Docker (option C) versions: (a) analysis of deep-sequencing data using the crIspresso webtool • tIMInG 10-120 min  crItIcal An illustrative video of the entire process is provided here: http://www.youtube.com/embed/ dXblIIiAe00?autoplay=1.
(i) Open a web browser and go to the CRISPResso page http://crispresso.rocks/.
(ii) Select the option for single-end (one FASTQ file) or paired-end reads (two FASTQ files) based on the type of deep sequencing performed. Analysis of paired-end reads requires overlapping sequence, as the paired reads will be merged. Upload the relevant FASTQ file(s) (as .fastq or .fastq.gz) for analysis. An example data set to test the tool with previously generated FASTQ files is provided at http://crispresso.rocks/help (see the 'Try it now!' section).
? troublesHootInG (iii) Input the amplicon sequence (required), sgRNA sequence (optional), and coding sequence(s) (optional input for when targeting exonic sequence). The reads uploaded in the previous step will be aligned to the provided amplicon sequence. If an sgRNA sequence is provided, its position will be indicated in all output analyses. If a coding sequence is provided, it will allow CRISPResso to perform frameshift analysis. The provided exonic sequence must be a subsequence of the amplicon sequence and not the sequence of the entire exon.
? troublesHootInG (iv) Adjust the parameters for window size (bp around each side of cleavage site) to quantify NHEJ edits (if sgRNA sequence is provided), minimum average read quality (Phred33 scale), minimum single-bp quality (Phred33 scale), exclude bp from the left side of the amplicon sequence for the quantification of the mutations, exclude bp from the right side of the amplicon sequence for the quantification of the mutations, and trimming adapter (see box 2 for a discussion of these parameters). (ii) Open a terminal and run the CRISPResso utility by running the following command. Here, we are assuming that the FASTQ files reads1.fastq.gz and reads2.fastq.gz are stored in the folder /home/user/ amplicons_data/.
CRISPResso \ -r1 /home/user/amplicons_data/reads1.fastq.gz \ -r2 /home/user/amplicons_data/reads2.fastq.gz \ -a AATGTCCCCCAATGGGAAGTTCATCTGGCACTGCCCACAGGTGAGG\ AGGTCATGATCCCCTTCTGGAGCTCCCAACGGGCCGTGGTCTGGTTCAT\ CATCTGTAAGAATGGCTTCAAGAGGCTCGGCTGTGGTT \ -g TGAACCAGACCACGGCCCGT \ -s 20 \ -q 30 \ -n BCL11A_exon2  crItIcal step Be sure to check whether or not the sequencing files were trimmed for adapters (refer to box 2 for further discussion of the trimming process and options).  crItIcal step The command is based on the example data from Step 83B(i) and must be amended before use. After the execution of the command, a new folder with all the results will be created; in this example, the folder will be in /home/user/amplicons_data/CRISPResso_on_BCL11A_exon2. A summary of the different events discovered in the sequencing data is presented in the Alleles_frequency_table.txt file, and in several illustrative plots (.pdf files). Refer to the online documentation for the full description of the output: https://github.com/pinellolab/CRISPResso. After the execution of the command, a new folder with all the results will be created; in this example, the folder will be in /home/user/amplicons_data/CRISPResso_on_BCL11A_exon2. A summary of the different events discovered in the sequencing data is presented in the Alleles_frequency_table.txt file, and in several illustrative plots (.pdf files). Refer to the online documentation for the full description of the output: https://github.com/pinellolab/CRISPResso. ? troublesHootInG analysis of a pooled sgrna experiment using crIspressocount • tIMInG 20 min-4 h  crItIcal CRISPRessoCount is a utility for the enumeration of sgRNA ( Fig. 2; box 4) . It is necessary to use the command-line or Docker version of CRISPResso to run CRISPRessoCount. CRISPRessoCount can enumerate sgRNAs from a user-generated list or can empirically identify all sgRNAs present in the FASTQ file.
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Gather the required data and information (adjust the entries as appropriate for the experiment): After the execution of the command, a new folder with all the results will be created; in this example, the folder will be in /home/user/amplicons_data/CRISPRessoCount_on_SAMPLE_SCREEN. This folder contains two files, the execution log (CRISPRessoCount_RUNNING_LOG.txt) and a file (CRISPRessoCount_only_ref_guides_on_sample_screen.fastq.gz.txt) containing a table with the raw and normalized counts for each sgRNA in the input FASTQ file: 86| Calculate the enrichment and/or dropout ('depletion') between two conditions, and calculate the log 2 ratio using the normalized sgRNA counts (this takes into account the total number of reads within each sequenced sample) using the 'Reads_Per_Millions_(RPM)' column for the two conditions. Refer to the 'CRISPResso: Analysis of deep sequencing from arrayed or pooled sgRNA experiments' section for further discussion of read normalization.  crItIcal step The log 2 transformation is not necessary, but is often used when displaying the data, as it will center the data at ~0 for an equal ratio; positive values will represent enrichment and negative values will represent depletion/dropout. ? troublesHootInG crIspresso analysis using crIspressopooled • tIMInG 20 min-4 h  crItIcal CRISPRessoPooled is a utility for analyzing and quantifying targeted sequencing CRISPR experiments involving sequencing with pooled amplicons. To use CRISPRessoPooled, it is necessary to use the command-line version of CRISPResso (see Step 83B). Although CRISPRessoPooled can be run in different modes (amplicon only, genome only, and mixed), in this protocol, we use the most reliable mode for quantification, called 'mixed mode' . In this mode, the amplicon reads are aligned to both reference amplicons and the genome to discard ambiguous or spurious reads. For more details regarding the different running modes, consult the online help (help is located below the list of files at the following link): https://github.com/pinellolab/CRISPResso.
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Gather the required data and information, including FASTQ files that contain reads for a pooled experiment with multiple sgRNAs, for example: Here, we are assuming that the file is saved in the folder /home/user/pooled_amplicons_data/ and is called AMPLICONS_FILE.txt After the execution of the command in the previous step, a new folder with all the results will be created. In this example, the folder will be in /home/user/amplicons_data/CRISPRessoPooled_on_Pooled_amplicons. In this folder, the user can find the following files: Or execute the following command for CRISPRessoPooledWGSCompare:
The syntax for the utility CRISPRessoPooledWGSCompare is exactly the same for results obtained with CRISPRessoWGS.
After the execution of the command CRISPRessoPooledWGSCompare, a new folder with subfolders (one for each region) will be created. In this example, the folder will be in /home/user/results/CRISPRessoPooledWGSCompare _on_comparison_sample1_sample 2.
In the folder created by CRISPRessoPooledWGSCompare, the user will see the following files: The paired-end reads are provided in a single file instead of the two that are required (a format usually referred to as interleaved)
In this case, it is necessary to use the command-line version of CRISPResso and add the option '--split_paired_end'
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CRISPResso is not performing frameshift analysis
The subsequence of the amplicon corresponding to the exon(s) is not provided
It is required to add the option '-e' to the command line to enable frameshift analysis. In addition, the sequence of the amplicon corresponding to the exon must be a subsequence of the reference amplicon. Refer to box 2 for further discussion of this parameter Step 83, CRISPResso analysis of deep-sequencing data: 10-120 min If an amplicon(s) is not reported in the analysis, check whether the sequence used in the amplicon description file is correct. In addition, check the '--min_reads_to_use_ region' parameter. This parameter allows for control over which amplicons have sufficient reads to be analyzed (default = 1,000). 
antIcIpateD results
Indel enumeration/analysis of a deep-sequencing amplicon generated by locus-specific PCR primers can be performed by CRISPResso for an arrayed experiment (Fig. 4a-d) . As a reference for assessment of locus-specific edits, we provide data demonstrating the quantification of editing (Fig. 4a) and distribution of combined insertions/deletions/substitutions , to show successful editing of BCL11A exon 2 with indels flanking the DSB site (Fig. 4b-c) . In this example, 36.1% of reads had a mutation present, whereas 63.9% of reads were unmodified (Fig. 4a) . Mutation position analysis demonstrated that the majority of indels clustered at the predicted sgRNA DSB site (Fig. 4b) , and indel size analysis demonstrated that most of the identified indels were small ( < 10 bp) (Fig. 4c) . Frameshift analysis was performed because coding sequence was targeted, which revealed a predominance of frameshift mutations (79.3% of reads) as compared with in-frame mutations (20.7% of reads) (Fig. 4d) . The distribution of all identified alleles can be directly visualized as well (supplementary Fig. 4) . Using CRISPRessoCompare for direct comparison of the sample treated with CRISPR/Cas9 with a non-edited control can offer reassurance that the identified mutations are likely to have resulted from CRISPR-mediated mutagenesis. Specifically, this analysis was performed by sequencing the mutagenized sample and a wild-type control, followed by analysis via CRISPRessoCompare (supplementary Fig. 5 ).
As a reference for assessment of a pooled CRISPR screen experiment, data are provided from two separate saturating mutagenesis experiments for identification of functional sequence within the BCL11A enhancer 11, 12 . All sgRNAs were designed within the core of the BCL11A enhancer. All sgRNAs were designed within BCL11A exon 2 to serve as positive controls and nontargeting controls were included as negative controls. sgRNAs were batch-cloned into pLentiGuide-puro, and lentivirus was produced. HUDEP-2 erythroid cells with stable Cas9 expression were transduced at low multiplicity. After puromycin selection and allowing 1-2 weeks for editing to occur, phenotypic selection occurred by FACS. Specifically, cells with high and low fetal hemoglobin (HbF) were sorted by FACS. gDNA was extracted from the high-and low-HbF sorted cell pellets. PCR was performed with primers specific to the pLentiGuide-Puro construct. After deep sequencing, FASTQ files were analyzed by CRISPRessoCount to determine read counts for each sgRNA in the library. Read counts were subsequently normalized for each sample. Normalized read counts from the high-HbF sample were divided by the normalized read counts from the low-HbF sample for each sgRNA, followed by a log 2 transformation to provide an enrichment score. The enrichment score for each sgRNA was plotted at the genomic position for the predicted DSB (Fig. 4e) . Notably, this analysis shows pooled experiments using NGG-and NGA-restricted sgRNA (supplementary table 1), and demonstrates reproducibility of the experimental results using this procedure across multiple studies. On the basis of the analysis presented in Figure 4e , enrichment of sgRNA based on HbF levels can be observed for sgRNAs targeting BCL11A coding sequence as compared with the nontargeting controls. Notably, the nontargeting sgRNAs cluster around an enrichment score of zero, suggesting no effect on HbF. The sgRNAs targeting the BCL11A enhancer demonstrate comparable enrichment to targeting BCL11A coding sequence and demonstrate substantial enrichment as compared with the nontargeting controls. Taken together, these saturating mutagenesis pooled screen experiments suggest that functional sequence exists within the BCL11A enhancer.
